Amyloid‐β PET in Alzheimer's disease: A systematic review and Bayesian meta‐analysis
Abstract Background In recent years, longitudinal studies of Alzheimer's disease (AD) have been successively concluded. Our aim is to determine the efficacy of amyloid‐β (Aβ) PET in diagnosing AD and early prediction of mild cognitive impairment (MCI) converting to AD. By pooling studies from d...
Main Authors: | Dan Ruan, Long Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Brain and Behavior |
Subjects: | |
Online Access: | https://doi.org/10.1002/brb3.2850 |
Similar Items
-
PET amyloid imaging: state of the art and technical considerations
by: Antonietta Arminio, et al.
Published: (2022-06-01) -
Development of software for measuring brain amyloid accumulation using 18F‐florbetapir PET and calculating global Centiloid scale and regional Z‐score values
by: Hiroshi Matsuda, et al.
Published: (2023-07-01) -
Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment
by: Hugh G. Pemberton, et al.
Published: (2023-05-01) -
PET imaging of 18F-florbetapir in cognitively impaired individuals: Lack of activity within the cerebellar cortex
by: Michael A. Meyer, et al.
Published: (2018-09-01) -
L’imaging dell’amiloide in PET: stato dell’arte e considerazioni tecniche
by: Antonietta Arminio, et al.
Published: (2022-06-01)